On the recordMarch 27, 2023
I am reintroducing my bipartisan bill, Increasing Transparency in Generic Drug Applications Act of 2022.
Source
congress.govI am reintroducing my bipartisan bill, Increasing Transparency in Generic Drug Applications Act of 2022.
Kuster reintroduces a bill to enhance generic drug market transparency.
Share & report
More from Ann Kuster
It establishes clear jurisdictional lines between financial regulators, helping to reduce regulatory complexity.
Unfortunately, that future and our Nation's ability to remain a global wireless leader came into question last night when the FCC's authority to auction spectrum was allowed to expire.